Restoration of hippocampal adult neurogenesis by CDRI‐08 (Bacopa monnieri extract) relates with the recovery of BDNF–TrkB levels in male rats with moderate grade hepatic encephalopathy

Abstract

AbstractModulation of in vivo adult neurogenesis (AN) is an evolving concept in managing neurodegenerative diseases. CDRI‐08, a bacoside‐enriched fraction of Bacopa monnieri, has been demonstrated for its neuroprotective actions, but its effect on AN remains unexplored. This article describes the status of AN by monitoring neuronal stem cells (NSCs) proliferation, differentiation/maturation markers and BDNF–TrkB levels (NSCs signalling players) vs. the level of neurodegeneration and their modulations by CDRI‐08 in the hippocampal dentate gyrus (DG) of male rats with moderate grade hepatic encephalopathy (MoHE). For NSC proliferation, 10 mg/kg b.w. 5‐bromo‐2′‐deoxyuridine (BrdU) was administered i.p. during the last 3 days, and for the NSC differentiation study, it was given during the first 3 days to the control, the MoHE (developed by 100 mg/kg b.w. of thioacetamide i.p. up to 10 days) and to the MoHE male rats co‐treated with 350 mg/kg b.w. CDRI‐08. Compared with the control rats, the hippocampus DG region of MoHE rats showed significant decreases in the number of Nestin+/BrdU+ and SOX2+/BrdU+ (proliferating) and DCX+/BrdU+ and NeuN+/BrdU+ (differentiating) NSCs. This was consistent with a similar decline in BDNF+/TrkB+ NSCs. However, all these NSC marker positive cells were observed to be recovered to their control levels, with a concordant restoration of total cell numbers in the DG of the CDRI‐08‐treated MoHE rats. The findings suggest that the restoration of hippocampal AN by CDRI‐08 is consistent with the recovery of BDNF–TrkB‐expressing NSCs in the MoHE rat model of neurodegeneration.